Abstract
We thank Dr. Kulkarni for the insightful comments about our manuscript. The randomized trial of tenapanor and phosphate binders as a dual-mechanism treatment for hyperphosphatemia in patients on maintenance dialysis[1][1] evaluated the effect of addition of the intestinal phosphate absorption
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
